Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Capital Expenditures (2016 - 2025)

Chemours has reported Capital Expenditures over the past 12 years, most recently at $185.0 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $185.0 million for Q4 2025, up 4725.0% from a year ago — trailing twelve months through Dec 2025 was $213.0 million (up 142.05% YoY), and the annual figure for FY2025 was $213.0 million, up 142.05%.
  • Capital Expenditures for Q4 2025 was $185.0 million at Chemours, up from -$99.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for CC hit a ceiling of $199.0 million in Q3 2022 and a floor of -$153.0 million in Q4 2023.
  • Median Capital Expenditures over the past 5 years was $44.0 million (2021), compared with a mean of $41.0 million.
  • Biggest five-year swings in Capital Expenditures: plummeted 1850.0% in 2021 and later surged 4725.0% in 2025.
  • Chemours' Capital Expenditures stood at -$105.0 million in 2021, then soared by 163.81% to $67.0 million in 2022, then tumbled by 328.36% to -$153.0 million in 2023, then soared by 97.39% to -$4.0 million in 2024, then surged by 4725.0% to $185.0 million in 2025.
  • The last three reported values for Capital Expenditures were $185.0 million (Q4 2025), -$99.0 million (Q3 2025), and $101.0 million (Q2 2025) per Business Quant data.